Log in to save to my catalogue

Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epiderm...

Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epiderm...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8628aa87b9354e758bff34a7cc0cba99

Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status

About this item

Full title

Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status

Publisher

London: BioMed Central Ltd

Journal title

BMC cancer, 2022-09, Vol.22 (1), p.1-11, Article 966

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Pathological stage IB-IIIA lung adenocarcinoma with an epidermal growth factor receptor (EGFR) mutation (Mt) has a high recurrence rate even after complete resection. However, there have been few reports on the risk factors for Mt recurrence. This study aimed to analyze the clinicopathological factors related to the relapse-free survival...

Alternative Titles

Full title

Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8628aa87b9354e758bff34a7cc0cba99

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8628aa87b9354e758bff34a7cc0cba99

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-022-10057-w

How to access this item